Sustainability Report

Overview

The report presents Insud Pharma's 2024 sustainability performance across Health for People, Planet and the company. It reports 8,833 active employees, 196,126 training hours, and Group GHG emissions of 24,990 tCO2e Scope 1, 21,225.52 tCO2e Scope 2 and 389,435.43 tCO2e Scope 3. The company describes a new ESG governance structure, a double materiality assessment, and a decarbonisation pathway with 50% target savings by 2035. Environmental disclosures include 226,345.66 MWh of energy consumption and renewable electricity expansion across European production sites.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services